Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis C

AIM: To predict which chronic hepatitis C patients are likely to be late-responders, we herein investigated the clinical characteristics of null-responders at 36 wk with hepatitis C virus (HCV) genotype Ib and a high viral load during the course of pegylated interferon (Peg-IFN)/ribavirin therapy. M...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Suzuki, Hideyuki, Kakizaki, Satoru, Horiguchi, Norio, Ichikawa, Takeshi, Sato, Ken, Takagi, Hitoshi, Mori, Masatomo
Formato: Artigo
Idioma:Inglês
Publicado: Baishideng Publishing Group Co., Limited 2010
Assuntos:
Brief Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3004033/
https://ncbi.nlm.nih.gov/pubmed/21173908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v2.i11.401
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares